Jin Song Xing

Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China.

Shanghai Xihua Scientific Co., Ltd. is a pharmaceutical testing company based in Shanghai, China. Xihua provides integrated services for the entire process of self-developed drug research and development to approval and listing for global pharmaceutical companies. The Chinese company has subsidiaries such as Xihua Pharmaceutical, Xihua Medicine, Xihua Medical, Suzhou Xihua, and Chuzhou Xihua, and also holds stakes in American companies, Purimai and TCM. The company was founded in 2015 by Jin Song Xing, who has been the CEO since then.